Paper36588686
The double-edged role of hydrogen sulfide in the pathomechanism of multiple liver diseases.
Liu B and 6 others. Front Pharmacol, 2022. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. The double-edged role of hydrogen sulfide in the pathomechanism of multiple liver diseases. Papers, record 36588686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36588686
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The double-edged role of hydrogen sulfide in the pathomechanism of multiple liver diseases.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References108
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33035509 | Mechanism of cystathionine-β-synthase inhibition by disulfiram: The role of bis(N,N-diethyldithiocarbamate)-copper(II). | Biochem Pharmacol | 2020 | https://conductscience.org/library/papers/33035509 | PubMed |
| 2 | 25937862 | Non-alcoholic fatty liver disease: The diagnosis and management. | World J Hepatol | 2015 | https://conductscience.org/library/papers/25937862 | PubMed |
| 3 | 21866187 | Interdependency of cystathione γ-lyase and cystathione β-synthase in hydrogen sulfide-induced blood pressure regulation in rats. | Am J Hypertens | 2012 | https://conductscience.org/library/papers/21866187 | PubMed |
| 4 | 31440595 | Hydrogen sulfide donor GYY4137 suppresses proliferation of human colorectal cancer Caco-2 cells by inducing both cell cycle arrest and cell death. | Heliyon | 2019 | https://conductscience.org/library/papers/31440595 | PubMed |
| 5 | 33546704 | The cancer metabolic reprogramming and immune response. | Mol Cancer | 2021 | https://conductscience.org/library/papers/33546704 | PubMed |
| 6 | 23846016 | Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/23846016 | PubMed |
| 7 | 32305523 | Cystathionine gamma-lyase/H2S system suppresses hepatic acetyl-CoA accumulation and nonalcoholic fatty liver disease in mice. | Life Sci | 2020 | https://conductscience.org/library/papers/32305523 | PubMed |
| 8 | 33090190 | The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A Review. | JAMA Oncol | 2021 | https://conductscience.org/library/papers/33090190 | PubMed |
| 9 | 32794154 | Role of serine protease inhibitor, ulinastatin, in rat model of hepatic encephalopathy: aquaporin 4 molecular targeting and therapeutic implication. | J Physiol Biochem | 2020 | https://conductscience.org/library/papers/32794154 | PubMed |
| 10 | 31439850 | Drug-induced liver injury. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/31439850 | PubMed |
| 11 | 32509026 | Hydrogen sulfide alleviates cognitive deficiency and hepatic dysfunction in a mouse model of acute liver failure. | Exp Ther Med | 2020 | https://conductscience.org/library/papers/32509026 | PubMed |
| 12 | 33092050 | The Status of Bile Acids and Farnesoid X Receptor in Brain and Liver of Rats with Thioacetamide-Induced Acute Liver Failure. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33092050 | PubMed |
| 13 | 26283969 | The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis. | Front Physiol | 2015 | https://conductscience.org/library/papers/26283969 | PubMed |
| 14 | 27565076 | Silymarin preconditioning protected insulin resistant rats from liver ischemia-reperfusion injury: role of endogenous H2S. | J Surg Res | 2016 | https://conductscience.org/library/papers/27565076 | PubMed |
| 15 | 24799983 | Global consequences of liver ischemia/reperfusion injury. | Oxid Med Cell Longev | 2014 | https://conductscience.org/library/papers/24799983 | PubMed |
| 16 | 30805080 | Hydrogen Sulfide as a Novel Regulatory Factor in Liver Health and Disease. | Oxid Med Cell Longev | 2019 | https://conductscience.org/library/papers/30805080 | PubMed |
| 17 | 33106666 | Acute liver failure is regulated by MYC- and microbiome-dependent programs. | Nat Med | 2020 | https://conductscience.org/library/papers/33106666 | PubMed |
| 18 | 30265375 | Hydrogen sulfide attenuates paraquat-induced epithelial-mesenchymal transition of human alveolar epithelial cells through regulating transforming growth factor-β1/Smad2/3 signaling pathway. | J Appl Toxicol | 2019 | https://conductscience.org/library/papers/30265375 | PubMed |
| 19 | 34570575 | Potential benefits of using hydrogen sulfide, vitamin E and necrostatin-1 to counteract acetaminophen‑induced hepatotoxicity in rats. | Bratisl Lek Listy | 2021 | https://conductscience.org/library/papers/34570575 | PubMed |
| 20 | 23758073 | Cystathionine γ-lyase deficiency protects mice from galactosamine/lipopolysaccharide-induced acute liver failure. | Antioxid Redox Signal | 2014 | https://conductscience.org/library/papers/23758073 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41496300 | Unlocking the gasotransmitter: hydrogen sulfide as a multitarget regulator in ischemia-reperfusion injury. | Med Gas Res | 2026 | https://conductscience.org/library/papers/41496300 | PubMed |
| 41420377 | Dietary methionine depletion and hydrogen sulfide-producing genes in perivascular adipose tissue of male Wistar rats. | Physiol Rep | 2025 | https://conductscience.org/library/papers/41420377 | PubMed |
| 41226825 | Hydrogen Sulfide in Balneology: Physiology, Evidence, and Clinical Translation. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226825 | PubMed |
| 38886098 | Digestive dynamics: Unveiling interplay between the gut microbiota and the liver in macronutrient metabolism and hepatic metabolic health. | Physiol Rep | 2024 | https://conductscience.org/library/papers/38886098 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| CASP9 | 842 | PubTator's text mining | https://conductscience.org/library/genes/842 | NCBI Gene |
| CBS | 875 | PubTator's text mining | https://conductscience.org/library/genes/875 | NCBI Gene |
| CTH | 1491 | PubTator's text mining | https://conductscience.org/library/genes/1491 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36588686
GET https://conductscience.org/api/papers/v1/36588686/references?page=2